NCT06844760View on ClinicalTrials.gov

Evaluation of Effectiveness and Safety of Stabilized Injectable Hyaluronic Acid (Perleux Body, Produced by Espad Pharmed Company) in the Neck Area

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 4, 2024

Primary Completion Date

October 24, 2024

Study Completion Date

October 24, 2024

Conditions

Skin Aging

Interventions

DEVICE

Hyaluronic Acid (HA)

Subjects will be treated with 2cc of Perleux body at baseline. After 4 weeks, a touch-up injection will be performed to achieve optimal improvement.

Trial Locations (1)

Unknown

Private Clinic, Tehran

All Listed Sponsors

lead

Espad Pharmed

INDUSTRY

NCT06844760 - Evaluation of Effectiveness and Safety of Stabilized Injectable Hyaluronic Acid (Perleux Body, Produced by Espad Pharmed Company) in the Neck Area | Biotech Hunter | Biotech Hunter